Division of Endocrinology Diabetes and Metabolism, Beth Israel Deaconess Medical Center, Boston, MA 02115.
Harvard Medical School, Boston, MA 02115.
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):E8458-E8467. doi: 10.1073/pnas.1706917114. Epub 2017 Sep 18.
Nuclear receptor corepressor 1 (NCoR1) is considered to be the major corepressor that mediates ligand-independent actions of the thyroid hormone receptor (TR) during development and in hypothyroidism. We tested this by expressing a hypomorphic NCoR1 allele (NCoR1ΔID), which cannot interact with the TR, in Pax8-KO mice, which make no thyroid hormone. Surprisingly, abrogation of NCoR1 function did not reverse the ligand-independent action of the TR on many gene targets and did not fully rescue the high mortality rate due to congenital hypothyroidism in these mice. To further examine NCoR1's role in repression by the unliganded TR, we deleted NCoR1 in the livers of euthyroid and hypothyroid mice and examined the effects on gene expression and enhancer activity measured by histone 3 lysine 27 (H3K27) acetylation. Even in the absence of NCoR1 function, we observed strong repression of more than 43% of positive T3 (3,3',5-triiodothyronine) targets in hypothyroid mice. Regulation of approximately half of those genes correlated with decreased H3K27 acetylation, and nearly 80% of these regions with affected H3K27 acetylation contained a bona fide TRβ1-binding site. Moreover, using liver-specific TRβ1-KO mice, we demonstrate that hypothyroidism-associated changes in gene expression and histone acetylation require TRβ1. Thus, many of the genomic changes mediated by the TR in hypothyroidism are independent of NCoR1, suggesting a role for additional signaling modulators in hypothyroidism.
核受体辅抑制因子 1(NCoR1)被认为是主要的辅抑制因子,在发育过程中和甲状腺激素受体(TR)的甲状腺功能减退症中介导配体非依赖性作用。我们通过在 Pax8-KO 小鼠中表达一种不能与 TR 相互作用的低功能 NCoR1 等位基因(NCoR1ΔID)来测试这一点,Pax8-KO 小鼠不能产生甲状腺激素。令人惊讶的是,NCoR1 功能的缺失并没有逆转 TR 在许多基因靶标上的配体非依赖性作用,也没有完全挽救这些小鼠因先天性甲状腺功能减退症而导致的高死亡率。为了进一步研究 NCoR1 在未配体结合的 TR 抑制中的作用,我们在甲状腺功能正常和甲状腺功能减退的小鼠的肝脏中删除了 NCoR1,并检查了对基因表达和增强子活性的影响,通过组蛋白 3 赖氨酸 27(H3K27)乙酰化来衡量。即使在缺乏 NCoR1 功能的情况下,我们也观察到在甲状腺功能减退的小鼠中,超过 43%的阳性 T3(3,3',5-三碘甲状腺原氨酸)靶基因被强烈抑制。大约一半的这些基因的调节与 H3K27 乙酰化的减少有关,并且几乎 80%的受影响 H3K27 乙酰化的区域包含一个真正的 TRβ1 结合位点。此外,使用肝脏特异性 TRβ1-KO 小鼠,我们证明了与甲状腺功能减退相关的基因表达和组蛋白乙酰化的变化需要 TRβ1。因此,甲状腺功能减退症中 TR 介导的许多基因组变化独立于 NCoR1,这表明在甲状腺功能减退症中存在其他信号转导调节剂的作用。